Literature DB >> 8895728

A mutation in the transforming growth factor beta type II receptor gene promoter associated with loss of gene expression.

T Muñoz-Antonia1, X Li, M Reiss, R Jackson, S Antonia.   

Abstract

Expression of transforming growth factor beta type II receptors (TbetaR-IIs) is either greatly decreased or absent in many tumors, implying that the loss of TbetaR-II function is one of the mechanisms leading to tumor development. In this report, we examine the expression of the TbetaR-II receptor in a squamous carcinoma cell line that expressed reduced levels of TbetaR-II mRNA. We found an A --> G mutation at position -364 of the 5' untranslated region of the TbetaR-II gene. This mutation results in significantly decreased transcriptional activity by the TbetaR-II gene promoter, suggesting that it is a primary mechanism of loss of TbetaR-II expression in this tumor cell line.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895728

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells.

Authors:  Hyo-Sung Jeon; Tatiana Dracheva; Sei-Hoon Yang; Daoud Meerzaman; Junya Fukuoka; Abbas Shakoori; Konstantin Shilo; William D Travis; Jin Jen
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

Review 2.  Molecular mechanisms of head and neck cancer.

Authors:  Amit M Deshpande; David T Wong
Journal:  Expert Rev Anticancer Ther       Date:  2008-05       Impact factor: 4.512

3.  Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas.

Authors:  S R Amoroso; N Huang; A B Roberts; M Potter; J J Letterio
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

4.  Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.

Authors:  T A McCaffrey; B Du; S Consigli; P Szabo; P J Bray; L Hartner; B B Weksler; T A Sanborn; G Bergman; H L Bush
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

5.  Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1.

Authors:  Kimberly A Brown; Amy-Joan L Ham; Cara N Clark; Nahum Meller; Brian K Law; Anna Chytil; Nikki Cheng; Jennifer A Pietenpol; Harold L Moses
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

6.  Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.

Authors:  Tania Fernandez; Stephanie Amoroso; Shellyann Sharpe; Gary M Jones; Valery Bliskovski; Alexander Kovalchuk; Lalage M Wakefield; Seong-Jin Kim; Michael Potter; John J Letterio
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

7.  TGFβ-1 and TGFBR2 polymorphisms, cooking oil fume exposure and risk of lung adenocarcinoma in Chinese nonsmoking females: a case control study.

Authors:  Yangwu Ren; Zhihua Yin; Kun Li; Yan Wan; Xuelian Li; Wei Wu; Peng Guan; Baosen Zhou
Journal:  BMC Med Genet       Date:  2015-04-10       Impact factor: 2.103

8.  Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro.

Authors:  Kimberly A Brown; Mary E Aakre; Agnieska E Gorska; James O Price; Sakina E Eltom; Jennifer A Pietenpol; Harold L Moses
Journal:  Breast Cancer Res       Date:  2004-03-17       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.